Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-030730
Filing Date
2021-05-06
Accepted
2021-05-06 19:00:39
Documents
2
Period of Report
2020-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6322
2 EX-24 DOCUMENT attachment1.htm EX-24 3705
  Complete submission text file 0001209191-21-030730.txt   11429
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584CM
Business Address
Geuijen Cecile A W (Reporting) CIK: 0001859721 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37773 | Film No.: 21899636